Joanne Shaw1, Helen Kamphuis1, Louise Sharpe2, Sophie Lebel3, Allan Ben Smith4, Nicholas Hulbert-Williams5, Haryana Mary Dhillon1,2,6, Phyllis Butow1. 1. Psycho-oncology Co-operative Research Group, Faculty of Science, School of Psychology, The University of Sydney, Sydney, NSW, Australia. 2. Faculty of Science, School of Psychology, The University of Sydney, NSW, Australia. 3. School of Psychology, University of Ottawa, Ottawa, ON, Canada. 4. Centre for Oncology Education and Research Translation (CONCERT), South Western Sydney Clinical School, Ingham Institute for Applied Medical Research, University of New South Wales, Sydney, NSW, Australia. 5. Centre for Contextual Behavioural Science, School of Psychology, University of Chester, Chester, United Kingdom. 6. Faculty of Science, Centre for Medical Psychology and Evidence-based Decision-making, The University of Sydney, NSW, Australia.
Abstract
BACKGROUND: Fear of cancer recurrence (FCR) is common amongst cancer survivors. There is rapidly growing research interest in FCR but a need to prioritize research to address the most pressing clinical issues and reduce duplication and fragmentation of effort. This study aimed to establish international consensus among clinical and academic FCR experts regarding priorities for FCR research. METHODS: Members of the International Psycho-oncology Society (IPOS) Fear of Cancer Recurrence Special Interest Group (FORwards) were invited to participate in an online Delphi study. Research domains identified in Round 1 were presented and discussed at a focus group (Round 2) to consolidate the domains and items prior to presentation in further survey rounds (Round 3) aimed at gaining consensus on research priorities of international significance. RESULTS: Thirty four research items were identified in Round 1 and 33 of the items were consolidated into six overarching themes through a focus group discussion with FCR experts. The 33 research items were presented in subsequent rounds of the delphi technique. Twenty one participants contributed to delphi round 1, 16 in round 2, and 25 and 29 participants for subsequent delphi rounds. Consensus was reached for 27 items in round 3.1. A further four research items were identified by panelists and included in round 3.2. After round 3.2, 35 individual research items were ratified by the panelists. Given the high levels of consensus and stability between rounds, no further rounds were conducted. Overall intervention research was considered the most important focus for FCR research. Panelists identified models of care that facilitate greater access to FCR treatment and evaluation of the effectiveness of FCR interventions in real world settings as the two research items of highest priority. Defining the mechanisms of action and active components across FCR/P interventions was the third highest priority identified. CONCLUSION: The findings of this study outline a research agenda for international FCR research. Intervention research to identify models of care that increase access to treatment are based on a flexible approach based on symptom severity and can be delivered within routine clinical care were identified as research areas to prioritize. Greater understanding of the active components and mechanisms of action of existing FCR interventions will facilitate increased tailoring of interventions to meet patient need.
BACKGROUND: Fear of cancer recurrence (FCR) is common amongst cancer survivors. There is rapidly growing research interest in FCR but a need to prioritize research to address the most pressing clinical issues and reduce duplication and fragmentation of effort. This study aimed to establish international consensus among clinical and academic FCR experts regarding priorities for FCR research. METHODS: Members of the International Psycho-oncology Society (IPOS) Fear of Cancer Recurrence Special Interest Group (FORwards) were invited to participate in an online Delphi study. Research domains identified in Round 1 were presented and discussed at a focus group (Round 2) to consolidate the domains and items prior to presentation in further survey rounds (Round 3) aimed at gaining consensus on research priorities of international significance. RESULTS: Thirty four research items were identified in Round 1 and 33 of the items were consolidated into six overarching themes through a focus group discussion with FCR experts. The 33 research items were presented in subsequent rounds of the delphi technique. Twenty one participants contributed to delphi round 1, 16 in round 2, and 25 and 29 participants for subsequent delphi rounds. Consensus was reached for 27 items in round 3.1. A further four research items were identified by panelists and included in round 3.2. After round 3.2, 35 individual research items were ratified by the panelists. Given the high levels of consensus and stability between rounds, no further rounds were conducted. Overall intervention research was considered the most important focus for FCR research. Panelists identified models of care that facilitate greater access to FCR treatment and evaluation of the effectiveness of FCR interventions in real world settings as the two research items of highest priority. Defining the mechanisms of action and active components across FCR/P interventions was the third highest priority identified. CONCLUSION: The findings of this study outline a research agenda for international FCR research. Intervention research to identify models of care that increase access to treatment are based on a flexible approach based on symptom severity and can be delivered within routine clinical care were identified as research areas to prioritize. Greater understanding of the active components and mechanisms of action of existing FCR interventions will facilitate increased tailoring of interventions to meet patient need.
Authors: Lynne I Wagner; Jenna Duffecy; Mark Begale; David Victorson; Shannon L Golden; Mary Lou Smith; Frank J Penedo; David C Mohr; David Cella Journal: Psychooncology Date: 2020-01-08 Impact factor: 3.894
Authors: Allan 'Ben' Smith; Louise Sharpe; Belinda Thewes; Jane Turner; Jemma Gilchrist; Joanna E Fardell; Afaf Girgis; Stephanie Tesson; Joseph Descallar; Melanie L Bell; Jane Beith; Phyllis Butow Journal: Support Care Cancer Date: 2018-06-07 Impact factor: 3.603
Authors: David Levy; Haryana M Dhillon; Anna Lomax; Michael Marthick; Catriona McNeil; Steven Kao; Judith Lacey Journal: Support Care Cancer Date: 2018-09-04 Impact factor: 3.603
Authors: Nina M Tauber; Mia S O'Toole; Andreas Dinkel; Jacqueline Galica; Gerry Humphris; Sophie Lebel; Christine Maheu; Gozde Ozakinci; Judith Prins; Louise Sharpe; Allan Ben Smith; Belinda Thewes; Sébastien Simard; Robert Zachariae Journal: J Clin Oncol Date: 2019-09-18 Impact factor: 44.544
Authors: Lynne I Wagner; Janet A Tooze; Daniel L Hall; Beverly J Levine; Jennifer Beaumont; Jenna Duffecy; David Victorson; William Gradishar; Joseph Leach; Thomas Saphner; Keren Sturtz; Mary Lou Smith; Frank Penedo; David C Mohr; David Cella Journal: J Natl Cancer Inst Date: 2021-11-02 Impact factor: 11.816
Authors: Jake R Thompson; Andrea L Smith; Serigne N Lo; Nadine A Kasparian; Robyn Pm Saw; Mbathio Dieng; Linda Seaman; Linda K Martin; Pascale Guitera; Donna Milne; Helen Schmid; Anne E Cust; Iris Bartula Journal: BMJ Open Date: 2022-03-03 Impact factor: 2.692